Remo Panaccione

Remo Panaccione

UNVERIFIED PROFILE

Are you Remo Panaccione?   Register this Author

Register author
Remo Panaccione

Remo Panaccione

Publications by authors named "Remo Panaccione"

Are you Remo Panaccione?   Register this Author

100Publications

2948Reads

25Profile Views

The Role of Bowel Ultrasound in Detecting Subclinical Inflammation in Pregnant Women with Crohn's Disease.

J Can Assoc Gastroenterol 2019 Dec 24;2(4):153-160. Epub 2018 Oct 24.

Division of Gastroenterology and Hepatology, Department of Medicine, University of Calgary, Alberta, Canada.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1093/jcag/gwy062DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6785691PMC
December 2019

Concomitant Use of Aminosalicylates Is Not Associated With Improved Outcomes in Patients With Ulcerative Colitis Escalated to Vedolizumab.

Clin Gastroenterol Hepatol 2019 Oct 7;17(11):2374-2376.e2. Epub 2018 Dec 7.

Division of Gastroenterology and Hepatology, University of Calgary, Calgary, Alberta, Canada. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.cgh.2018.11.062DOI Listing
October 2019

Crohn's-like disease in a patient exposed to anti-Interleukin-17 blockade (Ixekizumab) for the treatment of chronic plaque psoriasis: a case report.

BMC Gastroenterol 2019 Sep 5;19(1):162. Epub 2019 Sep 5.

Division of Gastroenterology, University of Calgary, HSC 1667, 2500 University Dr. NW, Calgary, Alberta, T2N4N1, Canada.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1186/s12876-019-1067-0DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6727530PMC
September 2019

Ustekinumab as Induction and Maintenance Therapy for Ulcerative Colitis.

N Engl J Med 2019 09;381(13):1201-1214

From the Dr. Henry D. Janowitz Division of Gastroenterology, Icahn School of Medicine at Mount Sinai, New York (B.E.S.); the Division of Gastroenterology, University of California, San Diego, La Jolla (W.J.S.), and the F. Widjaja Foundation Inflammatory Bowel and Immunobiology Research Institute, Cedars-Sinai Medical Center, Los Angeles (S.T.) - both in California; the Departments of Medicine and Community Health Sciences, University of Calgary, Calgary, AB, Canada (R.P.); Janssen Research and Development, Spring House, PA (C.D.O., H.Z., J.J., O.J.A., K.L., P.S., C.M.); the Gastroenterology Department and INSERM 1256, Nutrition, Genetics, and Environmental Risk Exposure, Nancy University Hospital, Université de Lorraine, Nancy, France (L.P.-B.); the Division of Gastroenterology and Hepatology, University Hospitals Leuven and Translational Research Center for Gastrointestinal Disorders, University of Leuven, Leuven, Belgium (G.V.A.); the IBD Center, Department of Gastroenterology, Humanitas Research Hospital and Humanitas University, Milan (S.D.); the Division of Gastroenterology, Department of Medicine, University of Miami Miller School of Medicine, Miami (M.T.A.); and the Division of Gastroenterology, Third Department of Internal Medicine, Kyorin University School of Medicine, Tokyo (T.H.).

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1056/NEJMoa1900750DOI Listing
September 2019

Outcomes and Strategies to Support a Treat-to-target Approach in Inflammatory Bowel Disease: A Systematic Review.

J Crohns Colitis 2019 Aug 12. Epub 2019 Aug 12.

Inflammatory Bowel Disease Clinic, Cumming School of Medicine, University of Calgary, Calgary, AB, Canada.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1093/ecco-jcc/jjz131DOI Listing
August 2019

Risk of Developing Additional Immune-Mediated Manifestations: A Retrospective Matched Cohort Study.

Adv Ther 2019 Jul 17;36(7):1672-1683. Epub 2019 May 17.

University of Calgary, Calgary, Canada.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s12325-019-00964-zDOI Listing
July 2019

Ulcerative Colitis: Shifting Sands.

Drugs R D 2019 Jun;19(2):227-234

Klinik für Innere Medizin I, Universitätsklinikum Schleswig-Holstein, Campus Kiel, 24105, Kiel, Germany.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s40268-019-0263-2DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6544716PMC
June 2019

Healthcare Providers Underestimate Patients' Glucocorticoid Use in Crohn's Disease.

Dig Dis Sci 2019 05 19;64(5):1142-1149. Epub 2019 Jan 19.

Christian-Albrechts University, Schittenhelmstrasse 12, 24105, Kiel, Germany.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s10620-018-5419-3DOI Listing
May 2019

Nutrition Center of Excellence (COE) in Inflammatory Bowel Disease-A Model and Rationale for Development.

J Can Assoc Gastroenterol 2019 May 6;2(2):63-70. Epub 2018 Jul 6.

Division of Gastroenterology, Cumming School of Medicine, University of Calgary, Calgary, Alberta, Canada.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1093/jcag/gwy028DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6507276PMC
May 2019

IL12/23 or selective IL23 inhibition for the management of moderate-to-severe Crohn's disease?

Best Pract Res Clin Gastroenterol 2019 Feb - Apr;38-39:101604. Epub 2019 Feb 19.

Robarts Clinical Trials, Inc. London, Ontario, Canada; Division of Gastroenterology, Western University, London, Ontario, Canada; Department of Epidemiology and Biostatistics, Western University, London, Ontario, Canada. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.bpg.2019.02.006DOI Listing
February 2019

An Unusual Cause of Esophageal Obstruction and Hematemesis.

Gastroenterology 2019 01 8;156(1):29-30. Epub 2018 Sep 8.

Division of Gastroenterology and Hepatology, University of Calgary, Calgary, Alberta, Canada.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1053/j.gastro.2018.07.051DOI Listing
January 2019

Pre-operative Exposure to Ustekinumab: A Risk Factor for Postoperative Complications in Crohn's Disease (CD)?

Curr Drug Targets 2019 ;20(13):1369-1372

Inflammatory Bowel Disease Unit, Division of Gastroenterology and Hepatology, University of Calgary, Calgary, Canada.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.2174/1389450120666190515094435DOI Listing
January 2019

Customized Use of Anti-Tumour Necrosis Factor-α Therapy During Pregnancy.

J Crohns Colitis 2018 11;12(11):1379-1380

Department of Medicine, University of Calgary, Alberta, Canada.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1093/ecco-jcc/jjy082DOI Listing
November 2018

Heterogeneity in Definitions of Efficacy and Safety Endpoints for Clinical Trials of Crohn's Disease: A Systematic Review.

Clin Gastroenterol Hepatol 2018 09 27;16(9):1407-1419.e22. Epub 2018 Mar 27.

Robarts Clinical Trials, Western University, London, Ontario, Canada; Department of Medicine, Western University, London, Ontario, Canada; Department of Epidemiology and Biostatistics, Western University, London, Ontario, Canada. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.cgh.2018.02.051DOI Listing
September 2018

Fistula-associated anal carcinoma in Crohn's disease.

Expert Rev Gastroenterol Hepatol 2018 Sep 24;12(9):917-925. Epub 2018 Jul 24.

c Inflammatory Bowel Disease Unit, Division of Gastroenterology and Hepatology , University of Calgary , Calgary , Canada.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1080/17474124.2018.1500175DOI Listing
September 2018

Real-world clinical, endoscopic and radiographic efficacy of vedolizumab for the treatment of inflammatory bowel disease.

Aliment Pharmacol Ther 2018 09 31;48(6):626-637. Epub 2018 Jul 31.

Inflammatory Bowel Disease Unit, Division of Gastroenterology and Hepatology, Cumming School of Medicine, University of Calgary, Calgary, AB, Canada.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1111/apt.14919DOI Listing
September 2018

Patterns and predictors of long-term retention of inflammatory bowel or rheumatoid disease patients on innovator infliximab: an analysis of a Canadian prescriptions claims database.

Patient Prefer Adherence 2018 18;12:1805-1814. Epub 2018 Sep 18.

Department of Medicine, Division of Gastroenterology, McMaster University and Farncombe Family Digestive Health Research Institute, Hamilton, ON, Canada,

View Article

Download full-text PDF

Source
http://dx.doi.org/10.2147/PPA.S171363DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6154729PMC
September 2018

Modern management of perianal fistulas in Crohn's disease: future directions.

Gut 2018 06 13;67(6):1181-1194. Epub 2018 Jan 13.

Division of Gastroenterology and Hepatology, Inflammatory Bowel Disease Unit, Cumming School of Medicine, University of Calgary, Calgary, Canada.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1136/gutjnl-2017-314918DOI Listing
June 2018

Lymphoma Risk and Overall Safety Profile of Adalimumab in Patients With Crohn's Disease With up to 6 Years of Follow-Up in the Pyramid Registry.

Am J Gastroenterol 2018 06 5;113(6):872-882. Epub 2018 Jun 5.

Academic Medical Center, Amsterdam, Netherlands. Medical university of Vienna, Vienna, Austria. Department of Medicine, university of Calgary, Calgary, Canada. Gastrointestinal Unit, Western General Hospital, Edinburgh, UK. AbbVie Inc., North Chicago, IL, USA. AbbVie Deutschland GmbH & Co. KG, Ludwigshafen, Germany. AbbVie Spain S.L.U., Madrid, Spain. Mayo Clinic, Division of Gastroenterology and Hepatology, Rochester, NY, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1038/s41395-018-0098-4DOI Listing
June 2018

Heterogeneity in Definitions of Endpoints for Clinical Trials of Ulcerative Colitis: A Systematic Review for Development of a Core Outcome Set.

Clin Gastroenterol Hepatol 2018 05 24;16(5):637-647.e13. Epub 2017 Aug 24.

Robarts Clinical Trials, Western University, London, Ontario, Canada; Department of Medicine, Western University, London, Ontario, Canada; Department of Epidemiology and Biostatistics, Western University, London, Ontario, Canada. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.cgh.2017.08.025DOI Listing
May 2018

Clinical disease activity in the CALM study - Authors' reply.

Lancet 2018 04;391(10129):1482

Academic Medical Centre, Amsterdam, Netherlands.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/S0140-6736(18)30775-XDOI Listing
April 2018

The old versus the new: which do you keep in postoperative Crohn's disease?

Intest Res 2018 Apr 30;16(2):319-320. Epub 2018 Apr 30.

Inflammatory Bowel Disease Unit, Division of Gastroenterology and Hepatology, University of Calgary, Calgary, Canada.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.5217/ir.2018.16.2.319DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5934608PMC
April 2018

A Randomized Trial Comparing High Definition Colonoscopy Alone With High Definition Dye Spraying and Electronic Virtual Chromoendoscopy for Detection of Colonic Neoplastic Lesions During IBD Surveillance Colonoscopy.

Am J Gastroenterol 2018 02 14;113(2):225-234. Epub 2017 Nov 14.

Inflammatory Bowel Disease Clinic Division of Gastroenterology & Hepatology, Department of Medicine, University of Calgary, Cumming School of Medicine, Calgary, Canada.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1038/ajg.2017.417DOI Listing
February 2018

Clinical utility of ustekinumab in Crohn's disease.

J Inflamm Res 2018 8;11:35-47. Epub 2018 Feb 8.

Inflammatory Bowel Disease Unit, Division of Gastroenterology and Hepatology, Cumming School of Medicine, University of Calgary, Calgary, AB, Canada.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.2147/JIR.S157358DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5810512PMC
February 2018

A Simple Ultrasound Score for the Accurate Detection of Inflammatory Activity in Crohn's Disease.

Inflamm Bowel Dis 2017 11;23(11):2001-2010

*Inflammatory Bowel Disease Clinic, Calgary Division of Gastroenterology and Hepatology, Alberta Health Services, and Department of Community Health Sciences, University of Calgary, Calgary, Alberta, Canada; †Department of Pediatrics, University of Toronto, Toronto, Ontario, Canada; and ‡Inflammatory Bowel Disease Clinic, Calgary Division of Gastroenterology and Hepatology, Alberta Health Services, and Department of Diagnostic Imaging, University of Calgary, Alberta, Canada.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/MIB.0000000000001174DOI Listing
November 2017

Asthma Is Associated With Subsequent Development of Inflammatory Bowel Disease: A Population-based Case-Control Study.

Clin Gastroenterol Hepatol 2017 Sep 23;15(9):1405-1412.e3. Epub 2017 Mar 23.

Department of Medicine, University of Calgary, Calgary, Alberta, Canada; Department of Community Health Sciences, University of Calgary, Calgary, Alberta, Canada; Synder Institute for Chronic Diseases, University of Calgary, Calgary, Alberta, Canada; O'Brien Institute for Public Health, University of Calgary, Calgary, Alberta, Canada. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.cgh.2017.02.042DOI Listing
September 2017

Crossover Subsets of CD4 T Lymphocytes in the Intestinal Lamina Propria of Patients with Crohn's Disease and Ulcerative Colitis.

Dig Dis Sci 2017 09 1;62(9):2357-2368. Epub 2017 Jun 1.

Gastrointestinal Research Group/Department of Medicine, HSC1838, University of Calgary, 2500 University Dr. NW, Calgary, AB, Canada.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s10620-017-4596-9DOI Listing
September 2017

Clinical Predictors of the Risk of Early Colectomy in Ulcerative Colitis: A Population-based Study.

Inflamm Bowel Dis 2017 08;23(8):1272-1277

*Division of Gastroenterology, University of Calgary, Calgary, Alberta, Canada; Departments of †Medicine, ‡Community Health Sciences, University of Calgary, Calgary, Alberta, Canada; and §Inflammatory Bowel Disease Clinic, University of Calgary, Calgary, Alberta, Canada.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/MIB.0000000000001211DOI Listing
August 2017

The NOD2-Smoking Interaction in Crohn's Disease is likely Specific to the 1007fs Mutation and may be Explained by Age at Diagnosis: A Meta-Analysis and Case-Only Study.

EBioMedicine 2017 Jul 16;21:188-196. Epub 2017 Jun 16.

Department of Medicine, University of Calgary, Calgary, Alberta, Canada; Department of Community Health Sciences, University of Calgary, Calgary, Alberta, Canada; O'Brien Institute for Public Health, University of Calgary, Calgary, Alberta, Canada; Faculty of Veterinary Medicine, University of Calgary, Calgary, Alberta, Canada; (i)Alberta Inflammatory Bowel Disease Consortium, University of Calgary, Calgary, Alberta, Canada. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.ebiom.2017.06.012DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5514403PMC
July 2017

The safety of vedolizumab for ulcerative colitis and Crohn's disease.

Gut 2017 05 18;66(5):839-851. Epub 2016 Feb 18.

Department of Medicine, Robarts Clinical Trials, Robarts Research Institute, University of Western Ontario, London, Ontario, Canada.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1136/gutjnl-2015-311079DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5531223PMC
May 2017

Long-term Maintenance of Clinical, Endoscopic, and Radiographic Response to Ustekinumab in Moderate-to-Severe Crohn's Disease: Real-world Experience from a Multicenter Cohort Study.

Inflamm Bowel Dis 2017 05;23(5):833-839

*Department of Medicine, Division of Gastroenterology, University of Calgary, Calgary, Alberta, Canada;†Department of Medicine, Division of Gastroenterology, University of Alberta, Edmonton, Alberta, Canada;‡Department of Medicine, Division of Gastroenterology, University of British Columbia, Vancouver, British Columbia, Canada; and§Institute of Translational Medicine, University of Birmingham, Birmingham, United Kingdom.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/MIB.0000000000001074DOI Listing
May 2017

Preoperative use of anti-tumor necrosis factor therapy in Crohn's disease: promises and pitfalls.

Intest Res 2017 Apr 27;15(2):160-165. Epub 2017 Apr 27.

Inflammatory Bowel Disease Unit, University of Calgary, Alberta, Canada.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.5217/ir.2017.15.2.160DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5430006PMC
April 2017

Point of Care Ultrasound Accurately Distinguishes Inflammatory from Noninflammatory Disease in Patients Presenting with Abdominal Pain and Diarrhea.

Can J Gastroenterol Hepatol 2016 20;2016:4023065. Epub 2016 Apr 20.

Inflammatory Bowel Disease Clinic, Division of Gastroenterology and Hepatology, University of Calgary, Calgary, AB, Canada T2N 2T9.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1155/2016/4023065DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4904691PMC
March 2017

Comparative Effectiveness of Mesalamine, Sulfasalazine, Corticosteroids, and Budesonide for the Induction of Remission in Crohn's Disease: A Bayesian Network Meta-analysis.

Inflamm Bowel Dis 2017 03;23(3):461-472

Departments of *Medicine and Community Health Sciences, †Community Health Sciences, and ‡Medicine, University of Calgary, Calgary, Alberta, Canada; and §Department of Medicine, Cedars-Sinai Medical Center, Los Angeles, California.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/MIB.0000000000001023DOI Listing
March 2017

Prevalence and Anatomic Distribution of Serrated and Adenomatous Lesions in Patients with Inflammatory Bowel Disease.

Can J Gastroenterol Hepatol 2017 15;2017:5490803. Epub 2017 Jan 15.

Department of Pathology and Laboratory Medicine, University of Calgary and Foothills Medical Centre, Calgary, AB, Canada.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1155/2017/5490803DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5274674PMC
March 2017

Predicting Outcomes to Optimize Disease Management in Inflammatory Bowel Diseases.

J Crohns Colitis 2016 Dec 9;10(12):1385-1394. Epub 2016 Jun 9.

The Henry D. Janowitz Division of Gastroenterology, Icahn School of Medicine at Mount Sinai, New York, NY, USA

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1093/ecco-jcc/jjw116DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5174730PMC
December 2016

Interpreting Registrational Clinical Trials of Biological Therapies in Adults with Inflammatory Bowel Diseases.

Inflamm Bowel Dis 2016 11;22(11):2711-2723

*Department of Medicine, University of Calgary, Calgary, Alberta, Canada; †Division of Gastroenterology, University of California San Diego, La Jolla, California; ‡Division of Gastroenterology, Icahn School of Medicine at Mount Sinai, New York, New York; §Robarts Clinical Trials, Robarts Research Institute, Department of Medicine, University of Western Ontario, London, Ontario, Canada; ‖Department of Medicine, Division of Gastroenterology and Hepatology, Feinberg School of Medicine, Northwestern University, Chicago, Illinois; ¶Department of Medicine, University Hospital Schleswig-Holstein, University of Kiel, Kiel, Germany; **INSERM Unité 954, Department of Gastroenterology, University of Lorraine, Nancy, France; ††Department of Gastroenterology, University Hospital Leuven, Leuven, Belgium; and ‡‡AbbVie Inc., North Chicago, Illinois.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/MIB.0000000000000909DOI Listing
November 2016

Vedolizumab for the treatment of ulcerative colitis.

Expert Opin Biol Ther 2016 9;16(1):129-35. Epub 2015 Dec 9.

b Inflammatory Bowel Disease Unit, Division of Gastroenterology and Hepatology , University of Calgary , Rm 6D32, TRW Building, 3280 Hospital Drive Northwest, Calgary , AB , Canada T2N 4N1.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1517/14712598.2016.1121231DOI Listing
September 2016

The Crohn's Disease-Ulcerative Colitis Clinical Appraisal Update: Emerging Trends in Clinical Practice.

Clin Gastroenterol Hepatol 2016 09 25;14(9):e121-2. Epub 2016 Jul 25.

Department of Hepato-Gastroenterology and Inserm U954, University Hospital of Nancy-Brabois, University of Lorraine, Vandoeuvre-lès-Nancy, France.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.cgh.2016.07.008DOI Listing
September 2016

Profiles of Lamina Propria T Helper Cell Subsets Discriminate Between Ulcerative Colitis and Crohn's Disease.

Inflamm Bowel Dis 2016 08;22(8):1779-92

*Department of Medicine/Gastroenterology, University of Calgary, Calgary, Alberta, Canada;†Department of Gastroenterology, Peking Union Medical College Hospital, Beijing, China;‡Calgary Laboratory Services, Calgary, Alberta, Canada;§Department of Pathology and Laboratory Medicine, University of Calgary, Calgary, Alberta, Canada; and‖Department of Production Animal Health, Faculty of Veterinary Medicine, University of Calgary, Calgary, Alberta, Canada.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/MIB.0000000000000811DOI Listing
August 2016

Novel CD8+ T-Cell Subsets Demonstrating Plasticity in Patients with Inflammatory Bowel Disease.

Inflamm Bowel Dis 2016 07;22(7):1596-608

Departments of *Medicine, and †Biological Sciences, University of Calgary, Calgary, Alberta, Canada; ‡Department of Gastroenterology, Peking Union Medical College Hospital, Beijing, China; §Department of Production Animal Health, University of Calgary, Calgary, Alberta, Canada; and ‖Department of Gastroenterology and Hepatology, Massachusetts General Hospital, Boston, Massachusetts.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/MIB.0000000000000848DOI Listing
July 2016

Targeted Biopsies Identify Larger Proportions of Patients With Colonic Neoplasia Undergoing High-Definition Colonoscopy, Dye Chromoendoscopy, or Electronic Virtual Chromoendoscopy.

Clin Gastroenterol Hepatol 2016 May 22;14(5):704-12.e4. Epub 2016 Jan 22.

Division of Gastroenterology, Department of Medicine, University of Calgary, Alberta, Canada. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.cgh.2015.12.047DOI Listing
May 2016

Bowel Ultrasonography in the Management of Crohn's Disease. A Review with Recommendations of an International Panel of Experts.

Inflamm Bowel Dis 2016 May;22(5):1168-83

*Gastroenterology Unit, Department of Systems Medicine, University of Rome Tor Vergata, Rome, Italy; †Ambulanzzentrum Gastroenterologie am Klinikum Lüneburg, Lüneburg, Germany; ‡Klinik für Allgemeine Innere Medizin und Gastroenterologie, Lüneburg, Germany; §Digestive Disease Center, Northwestern University Feinberg School of Medicine, Chicago, Illinois; ‖Division of Gastroenterology and Hepatology, Mayo Clinic College of Medicine, Rochester, Minnesota; ¶Division of Gastroenterology, Department of Medicine, University of Calgary, Calgary, Canada; **Department of Clinical Sciences, L. Sacco University Hospital, Milan, Italy; ††University Hospital Erlangen, Erlangen, Germany; and ‡‡Department of Gastroenterology and Hepatology, Tokyo Medical and Dental University Hospital, Tokyo, Japan.

View Article

Download full-text PDF

Source
http://pdfs.journals.lww.com/ibdjournal/2016/05000/Bowel_Ult
Web Search
http://dx.doi.org/10.1097/MIB.0000000000000706DOI Listing
May 2016

The role of vedolizumab in patients with moderate-to-severe Crohn's disease and ulcerative colitis.

Therap Adv Gastroenterol 2016 May 7;9(3):330-8. Epub 2016 Mar 7.

Inflammatory Bowel Disease Unit, Division of Gastroenterology and Hepatology, University of Calgary, Room 6D32, TRW Building, 3280 Hospital Drive Northwest, Calgary, AB, T2N 4N1, Canada.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1177/1756283X16635081DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4830105PMC
May 2016

Immunogenicity of Influenza Vaccine for Patients with Inflammatory Bowel Disease on Maintenance Infliximab Therapy: A Randomized Trial.

Inflamm Bowel Dis 2016 Mar;22(3):638-47

*Division of Pediatric Gastroenterology, Department of Pediatrics, Faculty of Medicine, University of Calgary, Alberta Children's Hospital; †Provincial Laboratory of Public Health (Microbiology); and ‡Division of Gastroenterology, Department of Medicine, Faculty of Medicine, University of Calgary, Foothills Medical Center.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/MIB.0000000000000615DOI Listing
March 2016

Early combined immunosuppression for the management of Crohn's disease (REACT): a cluster randomised controlled trial.

Lancet 2015 Nov 3;386(10006):1825-34. Epub 2015 Sep 3.

Robarts Clinical Trials Inc, Robarts Research Institute, London, ON, Canada; Department of Medicine, University of Western Ontario, London, ON, Canada; Department of Epidemiology and Biostatistics, University of Western Ontario, London, ON, Canada. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/S0140-6736(15)00068-9DOI Listing
November 2015

Postoperative Mortality Among Patients With Inflammatory Bowel Diseases: A Systematic Review and Meta-analysis of Population-Based Studies.

Gastroenterology 2015 Oct 6;149(4):928-37. Epub 2015 Jun 6.

Division of Gastroenterology, University of Calgary, Calgary, Alberta, Canada; Department of Medicine, University of Calgary, Calgary, Alberta, Canada; Department of Community Health Sciences, University of Calgary, Calgary, Alberta, Canada; Inflammatory Bowel Disease Clinic, University of Calgary, Calgary, Alberta, Canada. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1053/j.gastro.2015.06.001DOI Listing
October 2015

Type I interferons for induction of remission in ulcerative colitis.

Cochrane Database Syst Rev 2015 Sep 14(9):CD006790. Epub 2015 Sep 14.

Robarts Clinical Trials, Robarts Research Institute, P.O. Box 5015, 100 Perth Drive, London, ON, Canada.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/14651858.CD006790.pub3DOI Listing
September 2015

Complete mucosal healing defined by endoscopic Mayo subscore still demonstrates abnormalities by novel high definition colonoscopy and refined histological gradings.

Endoscopy 2015 Aug 31;47(8):726-34. Epub 2015 Mar 31.

Department of Pathology and Laboratory Medicine, University of Calgary, Alberta, Canada.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1055/s-0034-1391863DOI Listing
August 2015

Clinical predictors of thiopurine-related adverse events in Crohn's disease.

World J Gastroenterol 2015 Jul;21(25):7795-804

Gordon W Moran, Marie-France Dubeau, Gilaad G Kaplan, Hong Yang, Bertus Eksteen, Subrata Ghosh, Remo Panaccione, Inflammatory Bowel Disease Clinic, Division of Gastroenterology, Department of Medicine, Cumming School of Medicine, University of Calgary, Alberta T2N 1N4, Canada.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.3748/wjg.v21.i25.7795DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4491966PMC
July 2015

Briakinumab for treatment of Crohn's disease: results of a randomized trial.

Inflamm Bowel Dis 2015 Jun;21(6):1329-40

*Inflammatory Bowel Disease Unit, Division of Gastroenterology, Department of Medicine, University of Calgary, Calgary, AB, Canada; †Division of Gastroenterology, University of California San Diego, La Jolla, California; ‡Center for Digestive and Liver Diseases, Inc., Mexico, Missouri; §Division of Gastroenterology, School of Medicine, University of Washington Medical Center, Seattle, Washington; ‖Consultants for Clinical Research, Cincinnati, Ohio; ¶Gastroenterology Associates of Central Georgia, Macon, Georgia; **Robarts Research Institute, University of Western Ontario, London, ON, Canada; ††University of Chicago, Chicago, Illinois; ‡‡Department of Medicine, McMaster University, Hamilton, ON, Canada; §§Inflammatory Bowel Disease Program, Gastroenterology, Hepatology and Nutrition, University of Utah, Salt Lake City, Utah; ‖‖Data and Statistical Sciences, AbbVie Inc., North Chicago, Illinois; and ¶¶Therapeutic Area Immunology, Pharmaceutical Development, AbbVie GmbH & Co. KG, Ludwigshafen, Germany.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/MIB.0000000000000366DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4450894PMC
June 2015